Three problems seem immediately apparent: the portrayal of his actions in a manner that seems to betray the absence of any analytical inquiry; an overwhelming focus on his agency at the exclusion of structure, or vice versa, and an oversimplification of his interests as single, dominant or static.
An environmental group that specializes in nuclear waste, the Institute for Energy and Environmental Research in Washington, complained that the agency had created an exclusion zone of about 11 miles around Yucca Mountain, within which the water standard would not apply.
Going further, we believe that an agreement to pay a PI on such a contingent basis renders a study inherently not credible and warrants its outright exclusion from agency consideration.
Four agencies said they were reviewing the exclusion collateralized debt obligations backed by trust preferred securities - or TruPS-backed CDOs - from the rule, which limits banks' ownership of funds.
The inclusion and exclusion criteria for policy agencies were established prior to recruiting trial participants.
The exclusion of the State Department's intelligence bureau and other agencies seemed unusual, several government officials said, because of the high-profile subject.
In the past, Taiwan has argued that its exclusion is illegal under the health agency's charter, which recognizes "peoples" as well as states.
Exclusion criteria included commercial research groups; government agencies; those that examined existing or proposed health policy and international health research organisations.
They say that the exclusion is counterproductive and has prevented the agency from funding those companies most likely to hit the jackpot.
The Center's November story detailed how the administration has awarded more than 179,000 exemptions known as "categorical exclusions" to stimulus projects funded by federal agencies, freeing those projects from normally required review under the National Environmental Policy Act, or NEPA.
Agency rejection of clinical trials from consideration or manufacturer exclusion of clinical trials occurred in many cases because of perceived irrelevance of either the dosing regimens of the drug under evaluation or of the comparator, and/or trial population.
